Drug Profile
Hyaluronidase - Halozyme
Alternative Names: Hyaluronidase human injection - Halozyme; Hylenex; HYLENEX® recombinant; rHuPH20Latest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator Halozyme Therapeutics
- Developer Avid Bioservices
- Class Antineoplastics; Glycoside hydrolases; Polysaccharide lyases
- Mechanism of Action Hyaluronic acid modulators; Hyaluronidase replacements; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Unspecified